-

Report

-

Report

The United States vs. Other Countries: Availability of Medicines Varies TC

Speaker Pelosi’s drug pricing plan would set U.S. prices for medicines based on the pricing policies of six foreign governments that restrict patient access to medicines.

-

Graphic

Understanding Prescription Medicine Spending

Medicines play a central role in transforming the trajectory of many debilitating diseases, reducing mortality and improving health outcomes and quality of life for patients. Today, prescription medicines account for just 14% of total health spending. While brand medicine manufacturers produce 100% of new medicines, they account for only half of medicine spending, or 7% of total spending on health care. Over the next decade, many novel medicines will further transform patient care, yet medicines are projected to remain a small and stable share of total health spending. Discussion of prescription medicine spending needs to consider five key facts.

-

Report

Industry Profile 2019

To download the full report, click here.

The Profile is PhRMA’s flagship publication for telling the story of the sector for nearly five decades. It outlines what the industry stands for—including key policy solutions—along with an advocacy toolkit on key issue areas. See the Related Resources below for toolkit items available this year.

-

Video

Barriers to results-based contracts

Results-based contracts—also known as value-based contracts—have the potential to lower costs for patients and the health system. Despite the promise of these innovative payment approaches, regulations instituted before innovative contracting approaches were developed can create uncertainty for biopharmaceutical companies looking to pursue these contracts and can discourage them from entering into these beneficial agreements.